Supernus Pharmaceuticals (SUPN) Prepaid Assets (2011 - 2026)
Supernus Pharmaceuticals (SUPN) posted quarterly Prepaid Assets of $55.8 million for Q2 2026, up 77.77% year-over-year from $31.4 million in Q2 2025, and down 28.48% on a QoQ basis from $78.1 million in Q1 2026.
Supernus Pharmaceuticals (SUPN) Prepaid Assets (2011 - 2026) Analysis & Trends
Supernus Pharmaceuticals has reported Prepaid Assets for 16 years, with the latest figure at $55.8 million in Q2 2026.
- Prepaid Assets for Q2 2026 came in at $55.8 million, up 77.77% year-over-year; the trailing twelve-month figure through Jun 2026 was $55.8 million (up 77.77% YoY), and the FY2025 annual result was $65.3 million, up 81.02% from the prior year.
- Prepaid Assets declined to $55.8 million in Q2 2026, from $78.1 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $78.1 million in Q1 2026 and troughed at $15.8 million in Q4 2022.
- A 5-year average of $34.3 million and a median of $26.1 million in 2022 frame the typical range for Prepaid Assets.
- The widest annual swing landed in 2024, when Prepaid Assets plunged 48.25%; it then surged 169.93% in 2026.
- A 5-year view of Prepaid Assets shows it stood at $15.8 million in 2022, then increased by 5.68% to $16.7 million in 2023, then jumped by 116.41% to $36.1 million in 2024, then surged by 81.02% to $65.3 million in 2025, then slipped by 14.51% to $55.8 million in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $55.8 million in Q2 2026, $78.1 million in Q1 2026, and $65.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Supernus Pharmaceuticals | 2.75 Bn | 2.37 Bn | 185.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 55.85 Mn |
| Mar 31, 2026 | 78.09 Mn |
| Dec 31, 2025 | 65.33 Mn |
| Sep 30, 2025 | 62.08 Mn |
| Jun 30, 2025 | 31.42 Mn |
| Mar 31, 2025 | 28.93 Mn |
| Dec 31, 2024 | 36.09 Mn |
| Sep 30, 2024 | 27.40 Mn |
| Jun 30, 2024 | 23.17 Mn |
| Mar 31, 2024 | 23.77 Mn |
| Dec 31, 2023 | 16.68 Mn |
| Sep 30, 2023 | 23.93 Mn |
| Jun 30, 2023 | 44.77 Mn |
| Mar 31, 2023 | 16.30 Mn |
| Dec 31, 2022 | 15.78 Mn |
| Sep 30, 2022 | 24.85 Mn |
| Jun 30, 2022 | 21.41 Mn |
| Mar 31, 2022 | 22.37 Mn |
| Dec 31, 2021 | 27.02 Mn |
| Sep 30, 2021 | 30.69 Mn |